Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis

Overview of attention for article published in Arthritis Research & Therapy, June 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

So far, Altmetric has seen 4 X posts from 2 X users, with an upper bound of 299 followers.

Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients… https://t.co/cojIOrBX0V

And don't miss our papers on Abatacept (http://t.co/B0row49KtO) and Nilotinib (http://t.co/erWw1VzK0x) therapies in scleroderma.

Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients… http://t.co/fi9S6TKf0R

Read our new gene expression subsets paper showing results of a clinical trial of abatacept (Orencia) in scleroderma http://t.co/tRJnuanONK

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.